Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Association between the plasminogen activator inhibitor-1 4G/5G polymorphism and risk of venous thromboembolism: a meta-analysis.

Thrombosis research - 1 Dec 2014

Wang Jiarong, Wang Chengdi, Chen Nan, Shu Chi, Guo Xiaojiang, He Yazhou, Zhou Yanhong

Abstract excerpt

INTRODUCTION: The plasminogen activator inhibitor-1 (PAI-1) 4G/5G polymorphism was considered to be associated with risk of venous thromboembolism (VTE), while evidence remains inadequate. To provide a more accurate estimation of this relationship, we performed an updated meta-analysis of all eligible studies. MATERIALS AND METHODS: A systematical search was performed in PubMed, EMBASE, Wanfang, China National...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Genetic Markers
Share to Genetic Predisposition to Disease

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Incidence

Share to Mutation

Share to Plasminogen Activator Inhibitor 1

Share to Polymorphism, Single Nucleotide

Share to Risk Factors

Share to Venous Thromboembolism

Source

Identifiers

PMID: 25450536
DOI: 10.1016/j.thromres.2014.09.035

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Association between the plasminogen activator inhibitor-1 4G/5G polymorphism and risk of venous thromboembolism: a meta-analysis.PMID 25450536Read ↗

Plasminogen activator inhibitor-1 (PAI-1) 4G/5G promoter polymorphisms and risk of venous thromboembolism - a meta-analysis and systematic review.Semantic proximity Read ↗

Association between the plasminogen activator inhibitor-1 4G/5G polymorphism and venous thrombosis. A meta-analysis.Semantic proximity Read ↗

Association between the plasminogen activator inhibitor-1 4G/5G polymorphism and venous thrombosisSemantic proximity Read ↗

Clinical impact of the PAI-1 4G/5G polymorphism in Chinese patients with venous thromboembolismSemantic proximity Read ↗

Investigation of Plasminogen Activator Inhibitor-1 (PAI-1) 4G/5G promoter polymorphism in Indian venous thrombosis patients: A case-control study.Semantic proximity Read ↗

Influence of decreased fibrinolytic activity and plasminogen activator inhibitor-1 4G/5G polymorphism on the risk of venous thrombosis.Semantic proximity Read ↗

Association of β-fibrinogen polymorphisms and venous thromboembolism risk: A PRISMA-compliant meta-analysis.Semantic proximity Read ↗

The effect of the plasminogen activator inhibitor-1 4G/5G polymorphism on the Venous thromboembolism risk after total knee arthroplastySemantic proximity Read ↗

Plasminogen Activator Inhibitor-1 Levels and PolymorphismsSemantic proximity Read ↗

Correlation between PAI-1 rs1799889 polymorphism and venous thromboembolism: A meta-analysis of 48 case-control studies.Semantic proximity Read ↗

The genetics of venous thromboembolism. A meta-analysis involving approximately 120,000 cases and 180,000 controls.Semantic proximity Read ↗

Is tissue-plasminogen activator gene polymorphism a risk factor for venous thromboembolism in every population?Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.